Feb 16, 2016 8:00am EST Tonix Pharmaceuticals Reports Top Line Results From Phase 2 Proof-of-Concept Clinical Study of TNX-201 in Episodic Tension-Type Headache
Feb 2, 2016 7:05am EST Tonix Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference